The selective D3 receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect l-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats-Reference-Cited by-同舟云学术

The selective D3 receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect l-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats

Published:2010-02 Issue:2 Volume:58 Page:528-536
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Mela Flora,Millan Mark J.,Brocco Mauricette,Morari Michele

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference55 articles.

1. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice;Accili;Proc. Natl. Acad. Sci. USA,1997

2. Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease;Andersson;Neurobiol. Dis.,1999

3. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194;Audinot;J. Pharmacol. Exp. Ther.,1998

4. Evidence for a functional role of the dopamine D3 receptors in the cerebellum;Barik;Brain Res.,1996

5. Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of l-DOPA-induced dyskinesia;Berthet;J. Neurosci.,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease;Biomolecules;2022-02-01

2. Recent Advances in Dopamine D3 Receptor Heterodimers: Focus on Dopamine D3 and D1 Receptor–Receptor Interaction and Striatal Function;Therapeutic Applications of Dopamine D3 Receptor Function;2022

3. New insights into pathogenesis of l-DOPA-induced dyskinesia;NeuroToxicology;2021-09

4. Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia;Biomedicines;2021-03-19

5. Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs;Neuropharmacology;2020-10